Skip to main content

Table 5 Univariate and multivariate analyses used to predict longer survival of patients with pancreatic ductal adenocarcinoma

From: High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylation

Variate

Univariate analysis

Multivariate analysis

P value

OR

95% CI

P value

OR

95% CI

Age

0.119

0.97

0.94–1.01

0.665

0.99

0.95–.1.03

Gender

0.807

1.12

0.44–2.85

0.939

1.05

0.29–3.83

Diabetes

0.522

0.74

0.29–1.87

0.631

0.75

0.23–2.47

Smoking

0.668

1.24

0.47–3.27

0.453

1.66

0.44–6.23

Stage*,#

0.005

2.69

1.33–6.21

0.007

2.75

1.32–5.71

Chemotherapy*,#

0.003

5.95

1.84–19.29

0.003

8.86

2.10–37.54

Fucosylation*,#

0.015

0.86

0.76–0.97

0.033

0.79

0.64–0.98

  1. Stage: early stage (stage I and II) versus advanced stage (stage III and IV)
  2. *P < 0.05 in univariate analysis; #P < 0.05 in multivariate analysis
Back to article page

Clinical Proteomics

ISSN: 1559-0275